对 "在顺铂诱导的急性肾损伤中，TAK1通过p38和ERK介导过度自噬 "的更正

IF 5.3

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE Pub Date : 2025-02-12 DOI:10.1111/jcmm.70414

{"title":"对 \"在顺铂诱导的急性肾损伤中，TAK1通过p38和ERK介导过度自噬 \"的更正","authors":"","doi":"10.1111/jcmm.70414","DOIUrl":null,"url":null,"abstract":"Zhou J, Fan Y, Zhong J, et al. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury. Journal of cellular and molecular medicine 2018;22(5):2908–2921. doi:10.1111/jcmm.13585.In Zhou Jun et al., the immunohistochemistry (IHC) image for sham in Figure 1H was inadvertently misused during the figure preparation process. This correction does not affect the figure legends or the conclusions drawn in the study. The correct figures are shown below.","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 3","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70414","citationCount":"0","resultStr":"{\"title\":\"Correction to “TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury”\",\"authors\":\"\",\"doi\":\"10.1111/jcmm.70414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Zhou J, Fan Y, Zhong J, et al. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury. Journal of cellular and molecular medicine 2018;22(5):2908–2921. doi:10.1111/jcmm.13585.In Zhou Jun et al., the immunohistochemistry (IHC) image for sham in Figure 1H was inadvertently misused during the figure preparation process. This correction does not affect the figure legends or the conclusions drawn in the study. The correct figures are shown below.\",\"PeriodicalId\":101321,\"journal\":{\"name\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"volume\":\"29 3\",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-02-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcmm.70414\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70414\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70414","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to “TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury”

查看原文本刊更多论文

Correction to “TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury”

Zhou J, Fan Y, Zhong J, et al. TAK1 mediates excessive autophagy via p38 and ERK in cisplatin-induced acute kidney injury. Journal of cellular and molecular medicine 2018;22(5):2908–2921. doi:10.1111/jcmm.13585.

In Zhou Jun et al., the immunohistochemistry (IHC) image for sham in Figure 1H was inadvertently misused during the figure preparation process. This correction does not affect the figure legends or the conclusions drawn in the study. The correct figures are shown below.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CiteScore

11.50

自引率

0.00%

发文量

期刊介绍： The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries. It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.